#HSPCs
Single-cell CRISPR screen maps epigenetic regulators of lineage specification and malignancies in human HSPCs
Single-cell CRISPR screen maps epigenetic regulators of lineage specification and malignancies in human HSPCs
Yuan et al. establish a scalable single-cell CRISPR platform in primary human HSPCs, linking 322 regulator perturbations to cell states and gene programs. The atlas identifies regulators associated with long-term repopulation and lineage-biased outputs and nominates PRDM10 as a candidate AML dependency.
dlvr.it
November 9, 2026 at 8:09 PM
Revolutionizing HSPC transplant: bypass genotoxic side effects with KIT-targeted monoclonal antibodies. Discoveries promise safer therapies with greater efficacy. PMID:42420446, Nature 2026, @Nature https://doi.org/10.1038/s41586-026-10737-8 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
Non-genotoxic transplantation and in vivo selection through epitope editing | Nature
The short-term and long-term effects of genotoxic pre-transplant conditioning remain barriers to the broader application of haematopoietic stem/progenitor cell (HSPC) transplantation and gene therapies1–4. Although monoclonal antibodies targeting KIT have been proposed as alternatives to chemotherapy or radiotherapy5–7, their pharmacokinetics hinder clinical applications owing to the risk of depleting transplanted HSPCs. Here, to address this issue, we identified amino acid changes in the extracellular domain of KIT that disrupt the binding of two therapeutic monoclonal antibodies8,9, which impair stem cell factor (SCF)-mediated signalling without affecting KIT expression or functionality. We exploited adenine base editing10 or prime editing11 to efficiently introduce these mutations in HSPCs and combined them with the disruption of the BCL11A erythroid enhancer to promote expression of fetal haemoglobin (HbF)12,13, a therapeutic approach for several haemoglobinopathies. This strategy
doi.org
November 3, 2026 at 10:00 PM
RRIDs were included in this in Journal of Clinical Investigation paper. Thanks for making your methods matter! #methodsmatter #accelerateopenscience #RRID
Edited HSPCs rescue frataxin deficiency and inflammation-driven multisystemic pathology in Friedreich’s ataxia mice
Read the full paper: Edited HSPCs rescue frataxin deficiency and inflammation-driven multisystemic pathology in Friedreich’s ataxia mice
doi.org
October 23, 2026 at 7:03 AM
Epigenetics Update - Single-cell CRISPR screen maps epigenetic regulators of lineage specification and malignancies in human HSPCs www.cell.com/cell-stem-ce...

#Epigenetics #Chromatin #CRISPR #StemCells #HSPCs
---

Perfect for cancer, immunology, and aging research; epigenometech.com
October 20, 2026 at 7:03 AM
Edited HSPCs overcome frataxin deficiency in Friedreich’s ataxia (FRDA) mice doi.org/10.1172/JCI2...

Sivakumar et al. show that gene-edited, autologous HSPCs stably engrafted in FRDA mice, increasing frataxin expression and improving pathology in multiple affected tissues.
October 19, 2026 at 3:03 PM
RRIDs were included in this in Cell Stem Cell paper. Thanks for making your methods matter! #STMpublishing #OpenScience #accelerateopenscience
Single-cell CRISPR screen maps epigenetic regulators of lineage specification and malignancies in human HSPCs
Read the full paper: Single-cell CRISPR screen maps epigenetic regulators of lineage specification and malignancies in human HSPCs
doi.org
October 16, 2026 at 7:01 AM
Online Now! Single-cell CRISPR screen maps epigenetic regulators of lineage specification and malignancies in human HSPCs #stemcells
Single-cell CRISPR screen maps epigenetic regulators of lineage specification and malignancies in human HSPCs
Yuan et al. establish a scalable single-cell CRISPR platform in primary human HSPCs, linking 322 regulator perturbations to cell states and gene programs. The atlas identifies regulators associated with long-term repopulation and lineage-biased outputs and nominates PRDM10 as a candidate AML dependency.
dlvr.it
October 13, 2026 at 11:36 PM
Each year, we offer a range of online & in person events on topics critical in MND care, to help HSPCs gain up-to-date knowledge & skills

Our aim is to help them provide the best possible care for people with #MND

Register for our first 2027 events👉 mndassociation.org/education-events
September 28, 2026 at 7:18 AM
When KAR function is disrupted, these components become uncoupled, leading to impaired endothelial-to-hematopoietic transition and reduced blood stem cell emergence.

I’m very grateful to all the collaborators and co-authors who made this work possible, and I hope you enjoy the story!
Kainate receptors coordinate primitive hematopoiesis and hemogenic niche organization to promote hematopoietic stem cell development
The adult hematopoietic system is established during embryogenesis through the generation of hematopoietic stem and progenitor cells (HSPCs) within specialized transient niches, yet the signaling mech...
www.biorxiv.org
September 23, 2026 at 6:23 PM
🧬Advancing gene editing safely. CRISPR can trigger DNA damage responses in hematopoietic stem cells, but inhibiting p38 MAPK blocks this pathway. By safeguarding genome integrity, this science elevates therapeutic precision and ensures safer patient outcomes www.sciencedirect.com/science/arti...
p38 MAPK inhibition safeguards genome integrity during gene editing of hematopoietic stem and progenitor cells
Ex vivo genome editing of hematopoietic stem and progenitor cells (HSPCs) holds significant therapeutic potential but remains constrained by genotoxic…
www.sciencedirect.com
September 22, 2026 at 12:21 PM
I'm recruiting a postdoc in my new group at @CRUK_MI.
Funded by @leukaemiauk.bsky.social @ash.hematology.org.

Existing models can't recreate the multi-mutation genotypes patients actually have.

Our approach: a transgenic Cas12a platform disrupting up to 4 loci simultaneously in single HSPCs.
September 20, 2026 at 1:25 PM
Mohankumar et al. demonstrated that #truncatinggRNAs to 15–19 nt narrows the #baseediting window to suppress bystander mutations across ABE and CBE platforms, with 17 nt guides optimizing target precision during transient delivery in primary CD34+ HSPCs. 🩸🤖 #BystanderEditing #HSPCs #GeneTherapy
September 18, 2026 at 5:03 AM
We wish to thank Shahan Siddiquey, who is a Staff Scientist at Thermo Fisher Scientific, and Dr. Omar Farah, who is a Field Applications Scientist at Thermo Fisher Scientific, for their incredible talk discussing human hematopoietic stem and progenitor cells (HSPCs).

#LRCellBio
September 16, 2026 at 4:58 PM
as well as program megabase deletions and inversions and chromosomal rearrangements. We present strategies to maximize efficiency + precision (such as inhibiting competing NHEJ), show activity in primary T cells and HSPCs, and benchmark against alternatives, with lots of new data from the preprint.
Prime assembly with linear DNA donors enables large genomic insertions - Nature
Prime assembly can initiate Gibson-like assembly in cells to generate gene insertions without double-stranded DNA breaks, recombinases or homology-directed repair.
www.nature.com
September 16, 2026 at 7:14 PM
Type 1 interferon perturbates clonal competition by reshaping human blood development
To define the effects of IFNα on WT and neoplastic hematopoiesis, we leveraged genotyping of transcriptomes (GoT) that simultaneously captures the mutation status and whole transcriptomes in thousands of single cells24. We focused on CALR-MUT ET25 due to heterogeneous molecular response despite clinical response in most patients13,26. To overcome interpatient variabilities, we applied GoT to fluorescence-activated cell sorting (FACS)-isolated CD34+ hematopoietic stem and progenitor cells (HSPCs) from serial (that is, baseline and treated) bone marrow biopsies from patients who were treated weekly with a pegylated form of IFNα for at least one year in clinical trials MPN-RC-111 and MPN-RC-112 (refs. 27,28) (Fig. 1a, Extended Data Fig. 1a,b and Supplementary Table 1; n = 8 baseline samples, 13 treated samples; additional 3 baseline samples from previous work24; 72% cells genotyped for CALR mutations). We incorporated time-point-specific barcoded antibodies29 to multiplex serial baseline and treated samples into the same experiments (Fig. 1b). We advanced GoT by incorporating immunophenotyping30 (GoT-IM). GoT-IM provided somatic genotyping, whole transcriptomes, immunophenotyping and treatment status for thousands of HSPCs. We integrated across the 24 samples, clustered the cells based on scRNA-seq and annotated the clusters31,32 based on canonical cell markers (Fig. 1c, Extended Data Fig. 1b–j and Supplementary...
www.nature.com
September 15, 2026 at 7:05 PM
UCLA researchers have developed a way to mass-produce cancer-fighting T cells from donated cord blood stem cells, engineered to target a protein found in many solid tumors instead of custom treatments for each patient.

Study: www.cell.com/cell-reports...

newsroom.ucla.edu/releases/sci...
Scalable generation of hematopoietic stem cell-engineered off-the-shelf mono-specific cytotoxic T cells targeting solid tumors
Zhu et al. develop a scalable, feeder-free platform to generate allogeneic NY-ESO-1-specific T (AlloESO-T) cells from human HSPCs. These mono-specific, cytotoxic T cells combine TCR-driven antigen spe...
www.cell.com
September 10, 2026 at 2:33 PM
Preliminary transcriptome profiling of induced pluripotent stem cell-derived hematopoietic stem and progenitor cells in Kawasaki disease
Preliminary transcriptome profiling of induced pluripotent stem cell-derived hematopoietic stem and progenitor cells in Kawasaki disease - PubMed
iPSC-derived HSPCs from patients with KD display altered immune-inflammatory transcriptional profiles and suppressed B-cell developmental signatures at the transcriptomic level. These preliminary findings suggest that early hematopoietic immune dysregulation may contribute to KD pathogenesis. We pro …
pubmed.ncbi.nlm.nih.gov
September 7, 2026 at 5:47 PM
Very happy to share the first pre-print from my postdoc work with @larsplus.bsky.social (which we also presented at the excellent @isehsociety.bsky.social Annual Meeting last weekend). Here we performed a CRISPRi Perturb-seq screen targeting >500 transcriptional regulators in ex vivo mouse HSPCs.
September 1, 2026 at 2:07 PM
First, we characterised gene expression and cell-state phenotypes of all these knockdowns in HSPCs, highlighting co-regulating genes (usually cofactors or proteins in the same complex) that group together by local transcriptomic effects upon perturbation.
September 1, 2026 at 2:07 PM
Online now: Scalable generation of hematopoietic stem cell-engineered off-the-shelf mono-specific cytotoxic T cells targeting solid tumors
Scalable generation of hematopoietic stem cell-engineered off-the-shelf mono-specific cytotoxic T cells targeting solid tumors
Zhu et al. develop a scalable, feeder-free platform to generate allogeneic NY-ESO-1-specific T (AlloESO-T) cells from human HSPCs. These mono-specific, cytotoxic T cells combine TCR-driven antigen specificity with NK-like cytotoxicity, achieving enhanced tumor targeting, durable persistence, and reduced CRS/GvHD risk, which support their potential as an off-the-shelf therapy for solid tumors.
dlvr.it
August 27, 2026 at 12:27 PM
Technically above my pay grade, but apparently more evidence of beneficial non-thermal RF effects, at a frequency of 2.85 GHz (open access).

link.springer.com/article/10.1...
Nonthermal radiofrequency radiation promotes hematopoietic stem and progenitor cells function by regulating Ca2+ efflux - Stem Cell Research & Therapy
Background Hematopoietic stem and progenitor cells (HSPCs) are crucial for blood production and regeneration. While their function is known to be regulated by diverse physical cues, the impact of perv...
link.springer.com
February 14, 2026 at 8:22 AM